Emerging studies suggest this peptide, a dual activator targeting both the gut-brain axis and another hormone, may provide a notable step forward for weight loss . Early clinical tests have demonstrated considerable reductions in abdominal mass , potentially exceeding other body composition therapies . Nevertheless , further assessment is needed to